|
Match
|
Document |
Document Title |
|
|
7612010 |
Use of metal complex compounds as oxidation catalysts
Use of metal complex compounds of formula (1) and/or (1′)
[L n Me m X p ] z Y q (1),
|
|
|
7595400 |
Process for the preparation of hexacyclic compounds
This invention relates to novel processes for the preparation of compounds of the formula [1], wherein R1, R2, R3 and R4 are as defined in the claims and description as well as pharmaceutically...
|
|
|
7589200 |
5-Fluoro-4N-phenyl-4-pyrimidineamine compounds
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods...
|
|
|
7585856 |
Resolvins: Biotemplates for novel therapeutic interventions
The present invention is generally drawn to novel isolated therapeutic agents, termed resolvins, generated from the interaction between a dietary omega-3 polyunsaturated fatty acid (PUFA) such as...
|
|
|
7537912 |
Methods of measuring luminogenic activity with a protected coelenterazine
A method of measuring the enzymatic activity of a luciferase includes contacting a luminogenic protein, such as a luciferase, with a protected luminophore to form a composition; and detecting light...
|
|
|
7511125 |
Pyrimidine derivatives for labeled binding partners
Compounds having structure (1)
wherein R 1 is —H a protecting group, a linker or a binding partner; and R 2 and R 34 are as defined in the specification. The invention also provides...
|
|
|
7501427 |
Quinazoline analogs as receptor tyrosine kinase inhibitors
This invention concerns quinazoline analogs of Formula I:
where an A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is...
|
|
|
7456281 |
Nucleic acid melting analysis with saturation dyes
Methods are provided for nucleic acid analysis wherein a target nucleic acid is mixed with a dsDNA binding dye to form a mixture. Optionally, an unlabeled probe is included in the mixture. A...
|
|
|
7427693 |
Polar liquid crystal
Compounds that are useful in compositions for flat panel displays, for example, are provided. The compounds provided are polar, and are useful in low threshold voltage mixtures. The compounds...
|
|
|
7420056 |
Substituted bicyclic imidazo-3-ylamine compounds
Substituted bicyclic imidazo-3-yl-amine compounds are provided, as well as processes for the production thereof and pharmaceutical formulations containing these compounds. The use of these...
|
|
|
7393367 |
Agent for dyeing keratin-based fibers
An agent for dyeing keratin-containing fibers, especially human hair, is comprised of a cosmetic carrier, and
(A) at least one compound of Formula I,
wherein each of R 1 , R 2 ...
|
|
|
7390814 |
Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
Substituted hexahydropyrazino[1,2-a]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments The invention relates to substituted...
|
|
|
7321033 |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
The invention is directed to 3-β-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention...
|
|
|
7307168 |
Process for the preparation of 3-{2-′4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one
The invention relates to a process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl
}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-on
e of the Formula...
|
|
|
7268229 |
Compounds to co-localize luminophores with luminescent proteins
A method of measuring the enzymatic activity of a luciferase includes contacting a luminogenic protein, such as a luciferase, with a protected luminophore to form a composition; and detecting light...
|
|
|
7238771 |
Dibenzodiazocine polymers
Dibenzodiazocine polymers, methods for producing dibenzodiazocine polymers, products formed from dibenzodiazocine polymers, and uses for such dibenzodiazocine polymers are provided.
|
|
|
7217717 |
Phenalene derivatives
Novel 1,3,4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives are disclosed. These compounds inhibit epidermal growth factor receptor (“EGFR”) tyrosine kinase. These compounds and...
|
|
|
7176310 |
Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
This invention is directed to compound of the following formula (I):
wherein R 1 , R 2 , R 3 and R 4 are as described herein. These compounds and pharmaceutical compositions containing the...
|
|
|
7160890 |
Compounds specific to adenosine A3 receptor and uses thereof
This invention pertains to compounds which specifically inhibit the adenosine A 3 receptor and the use of these compounds to treat a disease associated with A 3 adenosine receptor in a subject,...
|
|
|
7138363 |
Use of metal complex compounds as oxidation catalysts
Use of metal complex compounds of formula (1) and/or (1′) [LnMemXp]zYq (1), [L′MemXp]zYq (1′), wherein all substituents are as defined in the claims, as catalysts for oxidation reactions, and...
|
|
|
7119111 |
2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use
Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and...
|
|
|
7109195 |
Hexacyclic compounds and their therapeutic use
The present invention relates to hexacyclic compound of the formula [1],
wherein Z, R 3 and R 4 are as identified therein, and pharmaceutically acceptable salts thereof. These compounds are...
|
|
|
7094783 |
Bicyclic pyrimidinones as coagulation cascade inhibitors
The present invention relates generally to compounds that inhibit serine proteases. In particular it is directed to novel amino-bicyclic pyrimidinone compounds of Formula (I):
or a stereoisomer...
|
|
|
7045624 |
Compounds and their uses
Use of a compound according to Formula [I]:
or a salt thereof to produce a cooling sensation, wherein R 1 and R 2 are independently selected from hydrogen or halogen atoms; hydroxy, cyano,...
|
|
|
6962991 |
Process for the synthesis of pyrazolopyrimidines
The present invention provides a nucleoside comprising a pyrazolopyrimidine base and a process for producing the same. In particular, the processes of the present invention comprises using a...
|
|
|
6846335 |
Crystal form of a perinone dye
A novel crystal form of C.I. Solvent Orange 60 gives a higher space-time yield in dye synthesis and is more easily finished.
|
|
|
6833455 |
Bridged perinones/quinophthalones
Disclosed herein are bridged perinones/quinophthalones of the general formula (I) or tautomeric forms thereof where X1, X2, Ar 1 Ar 2 and B are as described herein and are particularly...
|
|
|
6831074 |
Pharmaceutically active compounds
The present invention provides a compound of formula (I): where Q is a group of formula: These compounds inhibit cyclic guanosine 3′,5′-monophosphate phosphodiesterases (cGMP PDEs). More...
|
|
|
6825194 |
Hexacyclic compounds
The present invention relates to hexacyclic compound of the formula [1], wherein Z, R 3 and R 4 are as identified therein, and pharmaceutically acceptable salts thereof. These compounds are...
|
|
|
6703504 |
Conformationally constrained compounds as dendrimer cores
There are provided novel chemical compounds and their uses in the preparation of polymers and oligomers, and the preparation of such compounds. In certain embodiments there are provided dendritic...
|
|
|
6692562 |
Process for making perylene pigment compositions
This invention relates to a process of preparing a perylene pigment compositions containing a reactive co-precipitated blend of (1) about 75 to about 99.9 mol %, relative to the pigment...
|
|
|
6683028 |
Cyclic guanidine derivatives and their use as pesticides
The invention relates to novel guanidine derivatives of the formula (I) in which A, R 1 , R 2 , R 3 and Z are as defined in the description, to a process for their preparation and to their use...
|
|
|
6562968 |
Method of purifying tetrodotoxin
The present invention relates to a new process of purifying tetrodotoxin using high performance liquid chromatograph technology.
|
|
|
6491847 |
Discotic liquid crystal and organic electroluminescence device using same
A novel class of discotic liquid crystals represented by the following formula was synthesized, and a layer thereof was incorporated in an organic electroluminescence device.
|
|
|
6491749 |
Core-extended perylene bisimides
The present inventions relates to nucleus-extended perylenebisimides of formula (I) intermediates in the preparation of compounds (I) and processes for the preparation of those intermediates and...
|
|
|
6380193 |
Fused tricyclic compounds, methods and compositions for inhibiting PARP activity
A compound of formula I: or a pharmaceutically acceptable salt, hydrate, ester, solvate, prodrug, metabolite, stereoisomer, or mixtures thereof.
|
|
|
6281355 |
Nitrogen-containing tetracyclic compounds
A nitrogen-containing tetracyclic compound represented by the formula: ##STR1## wherein Y 1 --Y 2 --Y 3 is N--CN or a group represented by the formula: CC--NR 3 (wherein R 3 is a...
|
|
|
6207671 |
Cycloalkano-pyridines
The cycloalkano-pyridines are prepared by reacting corresponding cycloalkano-pyridine-aldehydes with suitable organometallic compounds or Wittig or Grignard reagents or reacting compounds of the...
|
|
|
6143748 |
Process for synthesis of nucleoside analogues
The present invention is concerned with a process for the preparation of antiviral 1,3-oxathiolane nucleosides comprising an intramolecular glycosylation reaction to produce exclusively the...
|
|
|
6140270 |
Process for the preparation of 6-(perfluoroalkyl) uracil compounds from 2-(N,N-disubstituted) amino-4-(perfluoroalkyl)-1,3-oxazin-6-one compounds
An improved process for the preparation of 6-(perfluoroalkyl)uracil compounds having the structural formula I ##STR1## from 2-(N,N-disubstituted)amino-4-(perfluoroalkyl)-1,3-oxazin-6-o
ne compounds...
|
|
|
6107304 |
Thieno[2,3-b]pyrazolo[3,4-d]pyridine-3-ones to enhance erythropoiesis
Invented are substituted thieno (2,3-b)pyrazolo(3,4-d)pyridin-3-ones, pharmaceutical compositions containing these compounds, and methods of using these compounds to enhance erythropoiesis. Also...
|
|
|
6093821 |
Process for preparing steroid receptor modulator compounds
Non-steroidal compounds which are high affinity, high selectivity modulators for steroid receptors are disclosed. Also disclosed are pharmaceutical compositions incorporating such compounds,...
|
|
|
5958923 |
Use of thiazole and thiadiazole compounds
The present invention relates to the use of thiazole and thiadiazole compounds of the following formula: ##STR1## where R 1 , A, B and Ar have the meanings stated in the description. The compounds...
|
|
|
5952335 |
Fused polycyclic heterocycle derivatives
Novel fused polycyclic heterocycle derivatives having excellent antitumor effects and a process for producing the same. A compound represented by the following general formula (I) or...
|
|
|
5948903 |
Synthesis of 3-deazapurines
This invention relates to compounds based on the 3-deazapurines ring system and to methods for making such compounds. The invention also generally relates to the field of "antisense" agents, agents...
|
|
|
5861398 |
Benzoperimidine-carboxylic acids and derivatives thereof
Benzo(e)perimidine-4-carboxamide derivatives of general structural formula I ##STR1## (where R a , R 1 , R 2 , R 3 , R 4 , R 5 , and R 6 are as defined in the specification) have activity for...
|
|
|
5830931 |
Process for the preparation of polycyclic compounds
Process for the preparation of compounds of the general formula (I) ##STR1## by reaction of aromatic dicarboxylic acids of the formula (II) ##STR2## or anhydrides and/or esters thereof with...
|
|
|
5808060 |
Fused isoindolones
Disclosed are biologically active, non-indole-containing compounds referred to as fused isoindolones, which are represented by the following general formula: ##STR1## The fused indolones can be...
|
|
|
5779934 |
Fluorine-containing optically active compound, process for preparing the same and liquid crystal mixture and liquid crystal element comprising the same
A fluorine-containing optically active compound represented by the formula (1): ##STR1## wherein R 1 is a saturated or unsaturated C 3 -C 20 alkyl group or a saturated or unsaturated C 3 -C 20 ...
|
|
|
5753663 |
Pyrimidine derivatives
The disclosed pyrimidine derivatives, and pharmaceutically acceptable salts thereof, exhibit useful pharmacological properties, in particular use as 5HT 2C - antagonists. The invention is also...
|